BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sigal SH, Amin A, Chiodo JA 3rd, Sanyal A. Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry. Can J Gastroenterol Hepatol 2018;2018:1579508. [PMID: 30363747 DOI: 10.1155/2018/1579508] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Alukal JJ, John S, Thuluvath PJ. Hyponatremia in Cirrhosis: An Update. Am J Gastroenterol 2020;115:1775-85. [PMID: 33156095 DOI: 10.14309/ajg.0000000000000786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Królicka AL, Kruczkowska A, Krajewska M, Kusztal MA. Hyponatremia in Infectious Diseases-A Literature Review. Int J Environ Res Public Health 2020;17:E5320. [PMID: 32718076 DOI: 10.3390/ijerph17155320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lu TL, Chang WT, Chan CH, Wu SN. Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor. Front Pharmacol 2019;10:76. [PMID: 30873020 DOI: 10.3389/fphar.2019.00076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]